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Understanding the attitudes and
acceptability of extra-genital Chlamydia
testing in young women: evaluation of a
feasibility study
Sally Brown1, Charlotte Paterson2, Nadine Dougall2, Sharon Cameron3 and Nick Wheelhouse1*
Abstract
Background: Chlamydia trachomatis (C. trachomatis) is the most common bacterial sexually transmitted infection in
the UK. Recent studies suggest that in addition to the genital tract, C. trachomatis is found in the throat and
rectum, suggesting the number of infections is under-reported. There is an urgent need to study the impact of
extending diagnosis to include extra-genital samples; however, there is a lack of evidence on the acceptability of
asking young women to provide these samples.
Method: A mixed methods single group feasibility study explored the acceptability of combined genital and extra-
genital testing in young women aged 16–25 years consecutively attending a sexual health centre in Edinburgh,
Scotland. Young women were asked to complete a self- administered anonymous questionnaire whether they
would be willing to give self-taken throat and ano-rectal samples. Interviews with women (n = 20) willing to self-
sample were conducted before and after self-sampling, and these explored the underlying reasons behind their
decision, and feelings about the tests.
Results: Of 500 women recruited to the study, 422 (84.4%) women provided sufficient data for analysis. From
completed questionnaires, 86.3% of respondents reported willingness to self-sample from the throat. Willingness of
ano-rectal self-sampling was lower (59.1%), particularly in women under 20 (< 20 years: 44.4%; ≥20 years, 68.2%).
Willingness of ano-rectal self-sampling was higher in women who had more sexual partners in the last 6 months (0
partners, 48.3%, n = 14, 3 or more partners, 67.4%, n = 60) and in those who have previous experience of a positive
test for a sexually transmitted infection (STI) (positive: 64.5%; negative: 57%). Interviewed women suggested that a
lack of knowledge of STIs, embarrassment and lack of confidence in the ability to carry out the sampling were
barriers towards acceptability.
Conclusions: In this study, self-sampling of throat samples is largely acceptable; however, the acceptability of
taking an ano-rectal sample for C. trachomatis testing in young women was lower in younger women. The study
suggests further research to investigate the acceptability of extra-genital testing as an addition to routine C.
trachomatis testing, and whether this increases detection and prevents infective sequelae for women.
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Background
Chlamydia trachomatis (C. trachomatis) is the single
most commonly diagnosed sexually transmitted bacterial
infection in the UK, with over 203, 000 cases in England
[1], and a further 15,685 cases in Scotland diagnosed in
2017 [2]. Young people are particularly at risk, with 67%
of diagnosed cases in patients under the age of 25,
equivalent to a detection rate of 1,882 per 100,000 popu-
lation within this cohort [1]. However, many cases of C.
trachomatis infection are clinically asymptomatic [3] and
remain undiagnosed, and as a consequence the actual
prevalence is likely to be higher. A recent Health Tech-
nology Assessment report highlighted a 17% risk of pel-
vic inflammatory disease (PID) after C. trachomatis
infection is untreated in women by the age of 44 [4],
with costs to the NHS of treatment of C. trachomatis in-
fections and subsequent complications estimated at be-
tween £37–£412 (approximately $57–$536) per case [5].
Current diagnostic protocols of C. trachomatis infection
in women involve sampling genital tract samples and
subsequent analysis by nucleic acid amplification test
(NAAT). These NAAT’s are validated for vulvo-vaginal
samples but they are required to be validated locally be-
fore they are used routinely [6]. Systematic analysis of
recent international clinical studies suggest that between
5 and 30% of infected women carry extra-genital chla-
mydial infections which sampling the genital tract alone
would fail to identify [7], suggesting that combined geni-
tal/ extra-genital testing regimens will increase detection
sensitivity. Extra-genital infections are also of clinical
significance. Rectal infections appear to be associated
with Azithromycin treatment failure [8], provide a reser-
voir for re-infection of the genital tract, and repeat re-in-
fection is associated with increased risk of complications
such as PID.
In women there is no clear association between re-
ceptive anal sex and rectal chlamydial diagnosis un-
like in men who have sex with men (MSM) where
targeted diagnostic protocols are effective. The recent
British Association for Sexual Health and HIV
(BASHH) national guidelines for the management of
infection with C. trachomatis conclude that ‘Further
studies with larger numbers of patients are needed to
ascertain the utility of targeted versus routine rectal
sampling in women’ [9]. However, the cited evidence
for favourable acceptability of self-taken rectal and
pharyngeal swabs in this report was restricted to
studies on MSM [9], a consequence of the poor exist-
ing published data on the acceptability of extra-genital
testing in women, in the UK. While there has been
no published work in this area from the UK a study
of women attending an STI clinic in the Netherlands
found that 94% (950 of 1012) were willing to under-
take extragenital testing [10].
It is well established that sexually transmitted infec-
tions are associated with stigma [11], and that attending
a sexual health clinic may also be perceived as stigmatis-
ing and embarrassing [12]. While there are many nega-
tive implications of a C. trachomatis diagnosis, including
shame, embarrassment and worry [13], Balfe et al. [14]
found that young women would be prepared to accept
opportunistic screening for chlamydia despite fearing
that their identities would be stigmatised, as they per-
ceived screening as a responsible act. Normalising
screening by offering it to everyone, rather than identify-
ing some people as ‘needing’ screening, would increase
acceptability [15].
The primary aim of this study was therefore to assess
the attitudes towards extra-genital testing of young
women undergoing STI testing using a mixed methods
approach of a survey and qualitative interviews.
Methods
Study design
This is a nonrandomised single group feasibility study
[16]. A mixed methods design was used to address the
following objectives: (1) What are young women’s atti-
tudes to being tested for extra-genital C. trachomatis; (2)
Does proposed willingness to complete self-sampling dif-
fer on socio-demographic factors, specifically age
(women < 20 years of age compared to women aged 20–
25), ethnicity, education level, deprivation level, smok-
ing, sexuality, number of sexual partners and self-re-
ported previous STI positivity; (3) What are women’s
attitudes to diagnostic protocols including extra-genital
testing in routine practice; Ethical approval was provided
by Edinburgh Napier University and NRES committee
North West- Preston (REC reference: 17/NW/0396).
Participants, setting and data collection
Women aged between 16 and 25 years old consecutively
attending a Sexual Health Centre in Edinburgh were
deemed eligible. The Sexual Health Centre provides a
range of sexual and reproductive health services to Edin-
burgh and the Lothians with a population of approxi-
mately 800, 000. People are referred by primary care
services or can self-refer via any of the drop-in clinics.
Approximately 500 women per month under the age of
20 routinely undergo Chlamydia testing at the Sexual
Health centre. Women who attended the clinics were in-
vited to complete a bespoke study questionnaire by the
receptionist.
If willing to take part, women were asked to complete
a bespoke quantitative questionnaire collecting informa-
tion regarding willingness to complete self-taken throat
and ano-rectal swabs, sexual activity, use of contracep-
tion, sexuality, previous STI testing (Additional file 1).
Demographic information (age, ethnicity, education, and
Brown et al. BMC Public Health          (2019) 19:992 Page 2 of 11
smoking) were also collected. A clinical research nurse
was on site to answer women’s questions. Completed
questionnaires were placed in an opaque envelope in a
sealed box. Women completed as much or as little as
they wished, and this did not influence their clinical
care. Consent for use of questionnaire data was implied
by completion. Prior to commencing the full study, the
questionnaire was piloted with 20 young women (aged
16–20 years) and appropriate amendments were made to
improve question clarity.
The final question of the questionnaire asked whether
women would take part in an interview about their atti-
tudes towards extra-genital testing. Participants were of-
fered a £10 voucher as in lieu of travel expenses for
taking part in the qualitative interview. Those who
wished to do so completed a tear off slip with their
name and contact number and placed that in a separate
opaque envelope, so that the research nurse could con-
tact them to arrange a date for interview with the quali-
tative researcher. Once the slip had been removed from
the questionnaire, the personal contact information
could not be linked to data provided in the question-
naire, which remained anonymous.
To address objectives one and three, we aimed to carry
out structured qualitative interviews with women who
were and were not willing to carry out extra-genital test-
ing (see Additional file 2 for the interview topic guide).
Informed written consent was obtained to participate in
recorded qualitative interviews. Twenty women who
were willing to carry out the test agreed to be inter-
viewed. They attended the clinic and had a short inter-
view about how they felt about testing, were then given
the testing kits by a research nurse and took a throat
and rectal swab themselves and were then interviewed
about the procedure. Pre- and post-test interviews were
conducted by two of the research team (SB and CP). Al-
though the interviews took place in a clinic setting, the
participants were informed during the consent process
that the interviewers were university rather than clinic
staff; we made the decision that the research nurse
would not conduct any of the interviews as it was felt
that participants could be less likely to report any nega-
tive feelings to her. However, although the setting itself
may have meant participants were more likely to report
positive views about the tests, many did discuss what
they felt were negative aspects of the testing. No women
who had indicated that they would not be willing to do
the tests volunteered to be interviewed.
Sample size
As recruitment rates were initially unknown, sample size
estimation was a two stage process. Firstly, using a 99%
confidence level (margin of error + or – 5%) to detect 50%
acceptability (i.e. 45–55%); with an estimated recruitment
rate of 70%, an estimated 952 women were required to be
approached to participate. From the first 250 women con-
sented, the sample size was re-estimated. Using a 95%
confidence level (margin of error + or – 5%), to detect a
60% (i.e. 55 to 65%) acceptability and an estimated recruit-
ment rate of 70% (based on the recruitment and accept-
ability rate at this stage) we aimed to consecutively
approach 528 women. We aimed to recruit for qualitative
interviews, sub-samples of women who were (n = 20) and
were not (n = 20) willing to carry out extra-genital testing,
to understand reasons for accepting or declining the test.
Analysis
Quantitative data were analysed using IBM SPSS 23.
Demographic and willingness responses and recruitment
rate (i.e. proportion of those who consented as a per-
centage of those who were invited to participate) were
presented as descriptive summaries for all participants
and for sub-groups of women (aged < 20 and > or = to
20 years). Specifically, means and standard deviations, or
medians and IQR were reported for continuous data
where appropriate, and count data and proportions were
reported for categorical data. Where proposed willing-
ness varied between subgroup categories, post-hoc ana-
lyses were conducted using chi-square test of
independence.
The qualitative interviews were recorded with the con-
sent of participants, and fully transcribed. Transcripts
were analysed by two of the research team (SB and CP)
using a Framework Analysis approach [17], which is ap-
propriate for analysing qualitative data in a multidiscip-
linary health-related project [18]. Framework Analysis
has five steps: familiarisation, identifying the framework,
indexing, charting, and mapping and interpretation. SB
and CP first familiarised themselves with the data by
reading all the transcripts independently, noting what
seemed to be the emerging themes. We then met to
jointly review the transcripts and our initial thoughts
about the coding framework. As the study was designed
around a specific set of issues, this guided the develop-
ment of the framework, but we also incorporated novel
themes, thus using both deductive and inductive ap-
proaches to ensure we did not miss any important
themes. Having developed our initial framework, we
again reviewed the transcripts independently before
meeting to compare our indexing and chart the data.
Any disagreements about coding were resolved through
discussions at these meetings. Having reached agreement
about the final indexing and charting, we then mapped
the data and worked on the interpretation together.
Results
Results are summarised in two sections, firstly the re-
sults from the questionnaire survey, followed by the
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findings from the interviews. The interview findings are
presented under the two key themes relating to accept-
ability that we drew from the analysis, feelings pre- and
post-test, and where testing takes place.
Sample description, recruitment rate, participation rate
During the study period, December 2018 to February
2019, 500 women were consecutively approached (i.e.
given the information sheet and questionnaire). Of the
500 approached, 71 (14%) did not return forms and were
therefore not included in the study. Seven patients
(1.4%) returned the survey but were not eligible (i.e. did
not meet the included age range) and were excluded
from the analysis, leaving a final sample of 422 (84.4%)
deemed to have consented and participated (see Fig. 1).
The target sample (n = 528) was not met, however this
target included a 30% increase to allow for refusal. The
target sample size before accounting for a 70% recruit-
ment rate (n = 369) was exceeded in reality (n = 422),
therefore power was not compromised. Furthermore,
when adjusted for the actual recruitment rate (84%), the
estimated target sample size would be n = 439, which
our sample exceeds. As 422 women were approached to
participate over the course of 3 months, this implies that
future work stemming from this epidemiological work
should plan to approach 164 eligible women per month,
to obtain a recruitment rate of 140 women per month.
Participant characteristics are presented in Table 1.
Women living in the most deprived areas are underrep-
resented in our sample (8%, n = 32), compared to the
Fig. 1 Flow-chart summarising study design and patient recruitment
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population residing in the council area of Edinburgh
(13%, n = 59, 280) [20]. Less educated women are also
underrepresented in our sample compared to the popu-
lation residing in the catchment area of NHS Lothian
[21] Of our sample, 97.5% had attained qualifications at
level 4 or above (n = 412) and fewer had no qualifica-
tions (2.5%, n = 10) compared to NHS Lothian (33.7%,
n = 233, 387, and 21%, n = 145, 434, respectively, [21].
There was also an overrepresentation of non-white
women in our sample (9%, n = 40), compared to the
Table 1 Participant characteristics and reported willingness to self-sample
Parameter Summary
data
Percentage of women who reported willingness to
complete self-sampled throat testing
Percentage of women who reported willingness to
complete self-sampled extra-genital testing
Age (n = 422) (m, SD) 20.5 (2.5) N/A N/A
Age group (n = 422): n (%)
Under 20 years 161 (38.2) 134 (83.2) 71 (44.4)
20 years and above 261 (61.8) 230 (88.1) 178 (68.2)
Total 422 (100) N/A N/A
Ethnicity (n = 422): n (%)
White 380 (90.0) 329 (86.6) 224 (59.1)
Self-identified as non-white 42 (10) 35 (83.3) 25 (59.5)
Total 422 (100) N/A N/A
Sexuality (n = 422): n(%)
Heterosexual 352 (83.4) 311 (88.4) 205 (58.4)
Other (Bisexual, prefer to self-describe,
gay, bisexual, prefer not to say)
70 (16.6) 53 (75.7) 44 (62.9)
Total 422 (100) N/A N/A
Education (n = 408): n (%)
No qualifications 9 (2.2) 7 (77.8) 5 (55.6)
Secondary education (compulsory)b 37(9.1) 28 (75.5) 13 (35.1)
Upper secondary education (optional)c 221 (54.2) 195 (88.2) 129 (58.6)
Vocational qualification (including SCQF
levels 4, 5, 6, 8 and 11)
18 (4.4) 13 (72.2) 9 (50.0)
Further educationd 118 (28.9) 105 (89.0) 81 (68.6)
Higher educatione 9 (2) 5 (100) 0 (0.00)
Total 408 (100) N/A N/A
Deprivation levela (n = 367): n(%)
Affluent 71 (19.3) 65 (91.5) 45 (63.4)
Intermediate 183 (49.9) 150 (82.0) 105 (57.4)
Deprived 16 (4.4) 14 (87.5) 7 (43.8)
Very deprived 97 (26.4) 85 (87.6) 61 (62.8)
Total 367 (100) N/A N/A
Smokers (n = 416): n (%)
Yes 110
(26.4%)
90 (81.8) 65 (59.1)
No 306 (74.6) 244 (87.5) 164 (59.0)
Total 416 (100) N/A N/A
Previously tested positive for an STI (n = 422): n (%)
Yes 121 (28.7) 114 (94.1) 78 (64.5)
No 301 (71.3) 250 (83.1) 171 (57.0)
Total 422 (100) N/A N/A
Not Applicable (N/A)
aDeprivation level as measured using Depcat score which is based on the Carstiars & Morris index of deprivation and has been widely used in Scotland. Edinburgh
is located in the health board catchment area of NHS Lothian [19]
bStandard grades, Intermediate grades 1 or 2; General Certificate of Secondary Education level 4;
cScottish Credit and Qualification Framework level 6–7; Higher and Advanced Higher Grades;
dHigher National Certificate;Higher National Diploma
eBatchelor degrees and other postgraduate degrees
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population in the catchment area of NHS Lothian (5.6%,
n = 46, 724) [21].
Data also revealed that willingness to self-sample did
not appear to be affected by education, deprivation or
ethnicity. For example, the proportions were broadly
similar for the summary data and those willing to self-
sample for education (across the columns lower educa-
tional attainment was 70.0% (n = 285/408), 68.8% (n =
243/353) and 65.8% (n = 156/237) respectively); for less
deprived areas (69.2, 68.5 and 68.8% respectively); and
regarding self as ‘white’ (90.0, 90.4 and 90.0% respect-
ively, all Table 1).
Data quality
Out of range responses were rare. Eighty (19%) partici-
pants had at least one missing data point, however this
only amounted to 1.6% missing data overall. Of the 19%,
55 participants (13%) did not complete a valid postcode,
suggesting that the missing data for postcode was not
missing at random, either participants did not know
their postcode or were less willing to complete this
question. As there was still less than 2% missingness
overall, no data imputation methods were used.
Quantitative acceptability response
More women reported willingness to self-sample a
throat swab (n = 364, 86.3%) than an ano-rectal swab
(n = 249, 59.1%). Of those who reported unwillingness to
self-sample a throat swab, 9% (n = 40) expressed concern
about taking the sample from the wrong place, 7% (n =
28) indicated wanting a healthcare professional to take
the sample, and 2% (n = 8) said they did not want any-
thing in the throat. Whether women had a previous ex-
perience of testing positive for an STI was statistically
significantly associated with increased willingness from
women who had previously tested positive (see Table 2).
Sexuality was also statistically significantly associated
with increased willingness to self-sample throat swabs,
however reported willingness tended remain high (>
70%) across subgroups (see Table 2).
Of the 422 women, 59.1% (n = 249) reported proposed
willingness to complete ano-rectal self-sampling,26.6%
(n = 112) reported being unwilling and 14.3% (n = 60)
were unsure. Eight percent (n = 33) of women expressed
not wanting anything to touch the ‘back passage’ (anus),
8% (n = 33) expressed concern about taking the sample
from the wrong place, 13% (n = 55) said they would pre-
fer a healthcare professional to take the sample, and 16%
(n = 69) said they did not want anything in the ‘back pas-
sage’ (anus).
Reported willingness to complete self-sampling of ano-
rectal testing was higher for those who were older than
20 years (44.4%) compared with those under 20 years
(68.2%); those who had sexual partners in the previous
6 months; and those who had previous experience of
testing positive for an STI. However only age groups
emerged as having a statistically significant association
(see Table 3) with willingness to self-sample.
Qualitative results
The anonymised quotes below are identified by partici-
pant number and age (i.e. P1/23). The interviewer is in-
dicated by ‘I’.
Feelings about the test
Almost all participants were unaware that the anus and
throat could be a reservoir for infection, and were happy
to do extra-genital testing if it gave more reliable results
than solely vaginal testing.
P: Obviously if it’s possible that you can have it
without it being detected by the other swab it’s really
good that it gets done in both areas [throat and
rectum] now so I’m fine.
I: Great. And how are you feeling about doing the anal
swab as well?
P: I’ve not done that one either. I guess I’m fine with it
as well. Like they wouldn’t do it if it wasn’t for a
purpose. So I guess if it means that it can protect
people it’s a good things so I’m fine with doing it
[laughs]. (P9/23)
This participant appeared to have a reasonable under-
standing of STIs and their transmission, but felt that as
others might not, expanding testing as well as raising
awareness was necessary.
Table 2 Associations of perceived willingness to self-sample throat swab
Variable Willingness n(%) Unwillingness n(%) Unsure n(%) Chi-square statistic (df) p-value
Previous positive STI test (n = 422) Yes n(%) 105 (94.1) 9 (7.3)b 9.11 (2) 0.01
No n(%) 250 (83.1) 6 (75.0) 51 (16.9)b
Sexuality (n = 422) Heterosexual n(%) 311 (88.4) 16 (4.5) 25 (7.1) 7.97 (2) 0.02
Othera n(%) 53 (75.7) 6 (8.6) 11 (15.7)
a(including bisexual, gay, lesbian, those who prefer to self-describe or not disclose)
bAggregated with women who were unsure due to sparse data for some options
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I guess you can still have STDs without them
coming up in the other tests. So it makes sense just
to make sure that it’s not in any other places. I
think it’s good cause a lot of people don’t realise
you can get STDs even through just oral sex. So I
think it’s quite good to raise awareness and also to
pick it up as quickly as possible. (P9/23)
Pre-test worries related to gagging while doing the
throat swab and discomfort while doing the rectal swab:
A little bit nervous about a throat swab just because
like even brushing my teeth I usually make myself gag
[laughs], so that’s just a little bit, I think it’ll be a bit
tricky to do it. (P2/22)
Probably both of them will be uncomfortable but I
don’t think it will be unbearable. (P14/19)
There was also some uncertainty about whether they
would do the ano-rectal test correctly as they had not
done one before:
And also, I suppose, would be a bit worried like
how far do you need to put that in for it to be, you
know, to work. Whereas, with the vaginal one,
because like I regularly, well not regularly but I
have, I have vaginal sex so like, you know, it can go
up where I don’t regularly do it the other side.
(P12/24)
Specific worries relating to the ano-rectal swab related
to embarrassment due to the part of the body being
tested.
I’d be a bit maybe embarrassed like if it came out and
there was like a bit of poo on it or something. (P12/24)
It’s not like scared but I’m being shy yeah. (P16/25)
However, despite worries about discomfort and ability
to do the tests correctly, all the women went on to see
the research nurse to be given the testing kits and in-
structions, and all but one did both tests, indicating that
these worries were insufficient to deter them from taking
the swabs. One participant changed her mind between
the first interview and doing the test, deciding that she
would only do the throat swab and not the ano-rectal
swab.
I’m just no too comfortable tae dae1 [pauses] things
like that eh. So … I just didnae2 fancy doing it (P1/23)
Once the women had completed the testing and given
the samples to the research nurse, they returned for a
short follow up interview. Acceptability of the tests was
high, with all participants saying that they would be pre-
pared to do the tests again, apart from the one woman
who had changed her mind about the rectal swab but
was happy to carry on doing throat swabs. All but this
one participant suggested that they could become part
of routine care. Indeed, one woman queried why they
were not already part of routine care for women, citing a
gay male friend who had told her that this type of testing
was regarded as routine for his community.
I was speaking to my friend who’s gay. And he told me
that at the men who have sex with men clinic it’s just
standard procedure. And we were saying, ‘well if it’s, if
it’s correct that it can, chlamydia can live elsewhere in
your throat or like anus, then why is it even a, why, why
do you even have a choice kind of thing? Like if they, like
why not just say, ‘you need these tests?’ (P11/24)
There was a sense of resigned acceptance in that many
of the women said they felt they should ‘just get on with
it’, comparing the tests to injections, blood tests or
Table 3 Associations of perceived willingness to self-sample ano-rectal swabs
Variable Willingness
n(%)
Unwillingness
n(%)
Unsure
n(%)
Chi-square statistic
(df)
p-
value
Age (n = 421) < 20 years n(%) 71 (44.4) 61 (38.1) 28 (17.5) 24.31 (2) 0.00
20 years and above
n(%)
178 (68.2) 51 (19.5) 32 (12.3)
Number of sexual partners in the last 6 months
(n = 418)
None n(%) 14 (48.3) 11 (37.9) 4 (13.8) 5.92 (6) 0.43
1 n(%) 87 (60.8) 35 (24.5) 21 (14.7)
2–3 n(%) 87 (55.4) 45 (28.7) 25 (15.9)
More than 3 n(%) 60 (67.4) 20 (22.5) 9 (10.1)
Previous positive STI test (n = 421) Yes n(%) 78 (64.5) 21 (17.4) 22 (18.2) 8.48 (2) 0.08
No n(%) 171 (57.0) 91 (30.3) 38 (12.7)
1Tae dae – to do
2Didnae – didn’t
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cervical smears in terms of an experience that they felt
was necessary despite it being unpleasant.
I just felt like I had tae just dae it, just for precaution
obviously (P1/23)
I just kind of think like no-one likes injections but
everyone just deals with it. (P11/24)
On the whole, participants who had expressed con-
cerns in the first interview said that taking the swabs
had not been as bad as they thought it would be; P7 had
previously said she felt nervous about the rectal swab:
P: It actually wasn’t as bad as I thought it would be. I
was kind of, like, dreading the anal swab, but it
actually wasn’t that bad.
I: What was it that you were dreading about it?
P: I don’t know, I just wasn’t sure if it was gonna be,
like, uncomfortable, or anything, but it wasn’t, it was
just kind of, I did it, it was over [laughs]. (P7/19)
Some of the participants had found the throat swab
made them gag, but apart from that it had not been a
problem to do it; there were more practical challenges
associated with the anorectal swab. Some had found the
test awkward to do, partly because it had been difficult
to find a comfortable position to insert the swab cor-
rectly, and partly because the swab itself was somewhat
flimsy which had made inserting it difficult:
I think the only thing with that one is that it was
maybe a bit like flimsy. So I found trying to kinda
guide, and I was sort of going, I was sort of using the
mirror [both laugh] sort of, trying to sort of guide it in
that way. I don’t know, maybe, it’d just be for me
personally maybe one that was just a little bit like
stiffer, I would have found more helpful. (P2/22)
The concern that some participants had expressed
prior to the tests, about whether they would do them
correctly, was reiterated by several of them after-
wards, with some uncertainty being expressed about
whether they had done the tests correctly, partly be-
cause they had not done them before, with most of
the reservations relating to the rectal test:
P: The mouth one was easy, the other one was a bit
more difficult cause I’d never had to do something like
that [laughs] so but it was fine yeah.
I: How was it difficult?
P: Just because I wasn’t really used to, well sticking
things [laughs] up there. (P9/23)
My only worry was, though, I still think, ‘did I do that
right?’ (P12/ 24)
Therefore, in terms of whether or not extra genital
testing is acceptable, all but one of the women who
returned to the clinic to do the tests said that they
would accept them as part of routine care, that they
understood how to do the tests, and found the instruc-
tions and the process to be clear. One was happy to do a
throat swab but had changed her mind about the rectal
swab and was uncertain about whether she would do the
test at another time.
Location
Participants were asked how they felt about visiting a
sexual health clinic, and for their views on the possibility
of home testing. The key themes identified related to
uncertainty and reassurance about the tests, and con-
venience versus stigma around attending a clinic.
Some participants felt that doing tests in a clinic
meant they would be more reliable:
I’d always be wary though ‘cause I’d feel like they wouldn’t
be as accurate… it seems more official here. (P15/19)
Although some liked the idea of home testing, they
suggested that the clinic might be preferable if they felt
unsure about how to do the test or whether they were
doing it correctly, because there would be someone on
hand that they could ask for guidance:
I think [home testing] would like be good unless I had
any questions because I knew that if I didn’t know
what to do I could come out and ask. (P14/19)
One participant suggested that home testing would be
a good option if a woman had learnt how to do the tests
at a clinic visit, and then felt confident they could do it
correctly at home:
I think it’s important to, for the first time you ever do
it to come into the clinic because I really wouldn’t
have known what I was doing. But I think once you’ve
done it once in the clinic, I think having the option to
do it at home if you’re pretty confident in what you
can do. (P20/21)
Some participants preferred to attend the clinic for test-
ing partly because it would be more inconvenient for them
to have to post samples back for testing than to do every-
thing (be given the kits, do the swabs, hand them back) on
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one site. There was also some concern about samples get-
ting lost in the post, or participants not knowing what had
happened to them once they had been posted.
I think I would prefer tae come in and just have it all
set up instead a’ posting it. I think it’s a hassle tae
post. I think it’s easier just to come in and have it all
in the one place. … Yeah I think like I can just come in
and everyone can just have the stuff there and give it
to me. And I can just leave it there and you can give
the results. But I think if you sent it out to me, I’d
have to like go back, post it. I wouldn’t know where it’s
going and things. (P13/21)
The main reason for wishing for home testing to be an
option was convenience.
I think it would probably…like maybe make me more
likely to do it. Like if I was really busy and I didn’t
have time to do the commute both ways and be like
wait to see somebody because obviously everybody here
is really busy. So maybe if I didn’t have a lot of time it
would be better to do it at home. (P14/19)
This partly related to the clinic being in a city centre
location, and services largely being centralised there so
that for most people, accessing sexual health services
means travelling in to the city centre.
An issue that was raised by several participants related to
whether or not a visit to a sexual health clinic was stigma-
tising. Whilst some felt that it was potentially embarrassing
to be seen entering the clinic, others suggested that attend-
ing sexual health services was becoming normalised:
I mean sometimes people are warned off coming to
these places because a’ the fear of someone they might
see or, like, I have been in this situation where I’ve, I’ve
taken my friend here and one of her past encounters
was sitting with us [laughs]. So yeah I can see where it
would be nice to have it at home and not have to deal
with a whole situation. (P18/22)
I think it’s quite…very accepted nowadays in that, in like
youth culture I guess. Like it’s not embarrassing to say that
you’re going to the clinic even if people other than your
friends overhear kind of thing. Like it’s very normalised. I
don’t think there’s that much of a stigma around it. (P11/24)
While this respondent felt that it was becoming ac-
cepted amongst younger age groups, another felt that
people would feel less embarrassed as they got older:
I think especially a lot of people, especially if they are
younger get embarrassed about coming in. … I think
it’s, I dunno, I think kind of like I’m at an age now I’m
kind of like I don’t see it as big deal. But I do
remember being like sixteen, seventeen and I’d always
be like, ‘oh I don’t want anyone to see me go in’. And
you’d be worried that everyone would be like, ‘oh
they’ve got chlamydia’. (P2/22)
Particularly where people are part of a small commu-
nity where everyone is known to each other, such as a
school, the assumptions made about attending the clinic
meaning ‘you’ve got chlamydia’ could result in a stigma-
tised identity just by being seen at the clinic.
Therefore, in terms of whether or not visiting a clinic
is acceptable, all the women felt that it was, although
they also acknowledged the risk of it being a stigmatising
encounter. Developing the option of doing these tests at
home would also be desirable, although with the clinic
was valued because of the advice and guidance available
from the staff who were seen as friendly, helpful and
non-judgemental.
Discussion
This feasibility study has demonstrated that extra genital
tract testing is largely acceptable in women aged 16–25
attending a sexual health clinic in Edinburgh, especially
for self-taken throat swabs. Reported willingness to
complete ano-rectal self-sampling was lower than that of
throat swabs, but the acceptability of ano-rectal self-
sampling was higher with increasing age. Specifically,
just less than half of women under 20 years reported be-
ing willing to complete ano-rectal self-testing testing
compared with two thirds of those women aged 20 to
25. Reported willingness to complete ano-rectal self-test-
ing was also higher in women who had any sexual part-
ners over the previous 6 months, and who had received
a prior diagnosis of an STI. This suggests a greater will-
ingness to undergo testing in women who perceive they
have been more at risk of acquiring an STI [22].
Qualitative data highlight women’s pre-test concerns,
primarily relating to discomfort or performing the test
incorrectly and embarrassment. These concerns over the
ability to conduct self-sample STI testing accurately by
young people are consistent with previous observations
[22]. After completing the tests, some women also re-
ported uncertainty in relation to their own conduct of
the self-tests and some discomfort, such as gagging dur-
ing the throat swab and awkward positioning during the
ano-rectal swab. Despite women having these concerns,
it has been demonstrated that there is actually good con-
cordance between the results gained from ano-rectal
self-sampling with those obtained in a clinic [23]. It has
been suggested to overcome the gagging response, that
mouth rinses may be an alternative to throat swabs for
both Neisseria gonorrhoeae and C. trachomatis, however
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this leads to an apparent reduction in sensitivity limiting
its clinical effectiveness [24]. Importantly, in terms of
clinical utility, women tended to report, post-test, that
they would do it again, despite such uncertainty and/or
discomfort, suggesting acceptability of including extra
genital testing in routine diagnostic assessment
procedures.
Qualitative data also suggested that women’s prefer-
ence over location (in clinic or at home) and administra-
tor (healthcare professional or self ) of the tests differed.
Such differences stemmed from women’s confidence in
their ability to administer the test correctly or not, but
also their perceived convenience of location. Women
discussed stigmatisation as a reason for preferring home
testing, with one participant suggesting this may be par-
ticularly true for younger people. Indeed, the shame as-
sociated with STI testing has been shown to be a
significant barrier to testing [25]. However, in a recent
study carried out in London, which compared the char-
acteristics of people (men and women) undergoing on-
line self-sample testing versus in clinic testing, 16–20
year olds were more likely to undergo testing within the
clinic setting. Conversely, 20–25 years olds were more
likely to use online self-sampling service [26]. This sug-
gests that younger people who perhaps have not under-
gone testing previously may have more confidence in
specialist expertise of clinical staff [27]. This may explain
the differences in acceptability for women under (less
acceptable) and over 20 years of age (more acceptable)
found in the quantitative data. However, further investi-
gation of why women under 20 years find extra-genital
testing less acceptable is required.
Strengths and limitations
This study is the only survey to date to assess the pro-
posed willingness to complete self-sampling for extrage-
nital C. trachomatis. The study had a good response rate
and our mixed-method approach has provided add-
itional information to that which a questionnaire-based
study alone would have failed to obtain. However, there
are limitations to the study. Within the survey, post-
codes had the lowest completion rate (13%, n = 55). It is
likely that this is not random and is indicative that par-
ticipants were not always willing to supply this informa-
tion, and partial postcode sufficient to capture derived
information on deprivation may be appropriate in future
studies. Our sample largely consists of white British
women, therefore limiting the generalisability of our re-
sults to women of other ethnicities. Our sample also
underrepresents less educated and more deprived
women. Data on young women’s education, deprivation
and ethnicity suggested that the acceptability of extra
genital testing did not change with respect to education
or deprivation levels, or whether participants’ identified
ethnicity was ‘white’ or otherwise. Furthermore, Depcat
[NHS Lothian Depcat) was used to measure deprivation
in this study, as opposed to the more widely used Scottish
Index of Multiple Deprivation (SIMD) [Scottish Govern-
ment SIMD]. Both measures calculate deprivation differ-
ently, making the comparison between our sample and
the population was challenging. Future studies should use
SIMD. The main limitation of the qualitative phase of the
study was that only women who were willing to return to
the clinic and take the tests were interviewed. Although
we invited women who did not want to do the testing to
be interviewed by telephone none volunteered. Therefore,
we are unable to identify factors that would prevent
women taking the tests, beyond those provided in answers
to the questionnaire.
Conclusions
This feasibility study indicates promising acceptability of
extra genital tract testing for Chlamydia trachomatis, es-
pecially for self-taken throat swabs. However, acceptabil-
ity of ano-rectal testing appears to be related to age,
with almost half of women under 20 reluctant to do this.
The reasons behind this need to be addressed, given the
high rates of C. trachomatis infection particularly in
women under 20 years of age. The results of the study
are broadly positive, and extragenital testing, particularly
at the ano-rectal site may increase the accuracy of C.
trachomatis diagnosis. Therefore, the results support fu-
ture clinical trials that involve women self-sampling
extragenital sites, to investigate if additional extra genital
testing to routine chlamydia testing does result in the
detection of more cases, and lead to the prevention of
infective sequelae for women.
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